© 2024 社團法人國家生技醫療產業策進會 & 財團法人生技醫療科技政策研究中心 版權所有
2020-08-14
To prevent the transfusion reaction, leuko-depletion before transfusion is a norm in most of the countries. PuriBlood is committed to improving the blood filtration process with innovative technology. Our products provide better and stable filtration performance, which can remove more than 99.99% of white blood cells and reduce filtration time.
Product features
● In compliance with FDA/CE guidance
● Short filtration time
● High WBC removal
● High RBC recovery
● Minimal volume loss
● Easy to use
For more product and technology details, please write to [email protected]
Booth No. L1318
Look for: Agents/distributors, and blood bank practitioners welcome to consult and collaborate